Startups blue-owl-private-credit-fund-raises-20-7m-canada similispharma@gmail.comMarch 28, 20260 The Canadian startup scene is abuzz with the latest news of Blue Owl’s private credit fund raising a whopping $20.7…
Startups uk-startups-financial-advisor-overcharged-me-15k similispharma@gmail.comMarch 28, 20260 The revelation that a financial advisor has overcharged a client by $15,000 over the course of a decade is a…
Startups applovins-shaping-startups-in-united-states similispharma@gmail.comMarch 28, 20260 As the tech landscape continues to evolve at an unprecedented pace, investors and analysts alike are keeping a close eye…
Investments dow-jones-futures-sell-off-broke-hearts-india similispharma@gmail.comMarch 28, 20260 As the world teeters on the brink of a potentially catastrophic conflict in the Middle East, the Dow Jones futures…
Investments liquidia-lqda-executive-sells-80k-shares-australia similispharma@gmail.comMarch 28, 20260 As the Australian investment landscape continues to evolve, a recent move by a high-ranking executive at Liquidia, a biotechnology company,…
Investments palantir-pltr-rating-boosts-canada-investments similispharma@gmail.comMarch 28, 20260 As Canadian investors continue to navigate the complex and ever-evolving landscape of the tech industry, a recent development has sent…
Investments uk-retirees-3-ultra-safe-dividend-stocks similispharma@gmail.comMarch 28, 20260 As the UK’s retirement landscape continues to evolve, one thing remains constant: the pursuit of stable, long-term income. With interest…
Investments teradyne-ter-stock-up-significantly-after-jim-cramer-united-states similispharma@gmail.comMarch 28, 20260 The recent surge in Teradyne’s stock price has left many investors and analysts scratching their heads, particularly after Jim Cramer,…
Business News india-business-news-dip-buyers-pull-gold-back similispharma@gmail.comMarch 28, 20260 As gold prices teetered on the edge of a bear market, a new wave of buyers has emerged to pull…
Business News why-jdiv-is-riskier-than-normal-dividend-growth-etf-in-australia similispharma@gmail.comMarch 28, 20260 As Australian investors continue to navigate the complexities of the local market, a growing concern has emerged regarding the JDIV…